PT2024748E - Anticorpos monoclonais anti-anexina a3 para a deteção de carcinoma da próstata - Google Patents
Anticorpos monoclonais anti-anexina a3 para a deteção de carcinoma da próstataInfo
- Publication number
- PT2024748E PT2024748E PT77259497T PT07725949T PT2024748E PT 2024748 E PT2024748 E PT 2024748E PT 77259497 T PT77259497 T PT 77259497T PT 07725949 T PT07725949 T PT 07725949T PT 2024748 E PT2024748 E PT 2024748E
- Authority
- PT
- Portugal
- Prior art keywords
- anexin
- monoclonal antibodies
- prostate carcinoma
- carcinoma detection
- detection
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57555—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the prostate
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4718—Lipocortins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Pathology (AREA)
- Gynecology & Obstetrics (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Reproductive Health (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pregnancy & Childbirth (AREA)
- General Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81208906P | 2006-06-09 | 2006-06-09 | |
| US85948906P | 2006-11-17 | 2006-11-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2024748E true PT2024748E (pt) | 2013-01-16 |
Family
ID=38653814
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT77259497T PT2024748E (pt) | 2006-06-09 | 2007-06-11 | Anticorpos monoclonais anti-anexina a3 para a deteção de carcinoma da próstata |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8012697B2 (https=) |
| EP (1) | EP2024748B1 (https=) |
| JP (1) | JP2009540278A (https=) |
| KR (1) | KR20090023372A (https=) |
| AU (1) | AU2007256377B2 (https=) |
| CA (1) | CA2654330A1 (https=) |
| DE (1) | DE07725949T1 (https=) |
| DK (1) | DK2024748T3 (https=) |
| ES (1) | ES2396730T3 (https=) |
| PL (1) | PL2024748T3 (https=) |
| PT (1) | PT2024748E (https=) |
| RU (1) | RU2467335C2 (https=) |
| WO (1) | WO2007141043A2 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1724586A3 (en) * | 2005-05-21 | 2007-07-04 | ProteoSys AG | Annexin for cancer risk assessment |
| EP2344544A2 (en) * | 2008-09-26 | 2011-07-20 | ProteoSys AG | Novel antibodies recognizing native annexin a3 |
| FR2968767B1 (fr) | 2010-12-08 | 2012-12-21 | Biomerieux Sa | Procede et coffret pour le diagnostic in vitro du cancer de la prostate |
| WO2013076222A1 (en) | 2011-11-23 | 2013-05-30 | Proteosys Ag | Differential annexin a3 measurements of serum and blood derivatives or fractions thereof for the diagnosis of prostate cancer |
| FR2991777B1 (fr) | 2012-06-07 | 2015-08-21 | Biomerieux Sa | Procede de detection et/ou de dosage de l'annexine a3 d'un mammifere dans le sang ou au moins un de ses derives |
| WO2015035941A1 (en) * | 2013-09-12 | 2015-03-19 | The University Of Hong Kong | Use of annexin a3 as a diagnostic and prognostic biomarker and therapeutic target for treating hepatocellular carcinoma |
| US9470677B2 (en) | 2013-11-28 | 2016-10-18 | Samsung Electronics Co., Ltd. | Cell with surface coated with ANXA1 and use thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4104910C3 (de) | 1991-02-18 | 2000-02-24 | Schloemann Siemag Ag | Stahlnachbehandlungsanlage |
| US5136855A (en) | 1991-03-05 | 1992-08-11 | Ontario Hydro | Heat pump having an accumulator with refrigerant level sensor |
| WO2003009814A2 (en) * | 2001-07-25 | 2003-02-06 | Millennium Pharmaceuticals, Inc. | Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer |
| DE10217254A1 (de) | 2002-04-15 | 2003-10-23 | Proteosys Ag | Verwendung von Substanzen zur Behandlung von Tumoren |
| JP5068543B2 (ja) * | 2004-02-16 | 2012-11-07 | プロテオジス アクチェンゲゼルシャフト | がんに関する診断マーカー |
| EP1724585A1 (en) * | 2005-05-21 | 2006-11-22 | ProteoSys AG | Annexin for cancer risk assessment |
| EP1724586A3 (en) * | 2005-05-21 | 2007-07-04 | ProteoSys AG | Annexin for cancer risk assessment |
-
2007
- 2007-06-11 KR KR1020087029969A patent/KR20090023372A/ko not_active Ceased
- 2007-06-11 CA CA002654330A patent/CA2654330A1/en not_active Abandoned
- 2007-06-11 EP EP07725949A patent/EP2024748B1/en active Active
- 2007-06-11 WO PCT/EP2007/005134 patent/WO2007141043A2/en not_active Ceased
- 2007-06-11 RU RU2008152009/15A patent/RU2467335C2/ru not_active IP Right Cessation
- 2007-06-11 ES ES07725949T patent/ES2396730T3/es active Active
- 2007-06-11 PL PL07725949T patent/PL2024748T3/pl unknown
- 2007-06-11 JP JP2009513608A patent/JP2009540278A/ja not_active Ceased
- 2007-06-11 PT PT77259497T patent/PT2024748E/pt unknown
- 2007-06-11 AU AU2007256377A patent/AU2007256377B2/en not_active Ceased
- 2007-06-11 DK DK07725949.7T patent/DK2024748T3/da active
- 2007-06-11 DE DE07725949T patent/DE07725949T1/de active Pending
- 2007-06-11 US US12/303,825 patent/US8012697B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US8012697B2 (en) | 2011-09-06 |
| EP2024748A2 (en) | 2009-02-18 |
| KR20090023372A (ko) | 2009-03-04 |
| AU2007256377B2 (en) | 2012-11-01 |
| WO2007141043A2 (en) | 2007-12-13 |
| RU2008152009A (ru) | 2010-07-20 |
| ES2396730T3 (es) | 2013-02-25 |
| AU2007256377A1 (en) | 2007-12-13 |
| CA2654330A1 (en) | 2007-12-13 |
| JP2009540278A (ja) | 2009-11-19 |
| RU2467335C2 (ru) | 2012-11-20 |
| DE07725949T1 (de) | 2009-07-02 |
| EP2024748B1 (en) | 2012-12-12 |
| DK2024748T3 (da) | 2013-03-18 |
| WO2007141043A3 (en) | 2008-03-20 |
| PL2024748T3 (pl) | 2013-05-31 |
| US20100233160A1 (en) | 2010-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LT3421498T (lt) | Monokloniniai antikūnai prieš klaudiną-18, skirti vėžio gydymui | |
| NO344963B1 (no) | Humanisert antistoff | |
| IL196470A (en) | Antagonist antibody for the treatment of cancer | |
| EP2121751A4 (en) | MONOCLONAL ANTIBODIES AGAINST ANGPTL3 | |
| DK2019840T3 (da) | Antagonist anti-human CD40 monoklonalt antistof. | |
| SI2178921T1 (sl) | Monoklonska protitelesa proti glipikan-3 | |
| IL197217B (en) | Novel anti-cd38 antibodies for the treatment of cancer | |
| EP2021373A4 (en) | MONOCLONAL ANTIBODY VCAM-1 SPECIFIC | |
| CR10705A (es) | Anticuerpos para linfotoxina-alfa | |
| ZA201000049B (en) | Monoclonal antibeta amyloid antibody | |
| EP2324359A4 (en) | MONOCLONAL ANTIBODY STRO-4 | |
| DK2115472T3 (da) | Cancerbiomarkører | |
| BRPI0814111A2 (pt) | Anticorpo monoclonal citotóxico anticâncer | |
| BRPI0918178A2 (pt) | anticorpos monoclonais para tratamento de câncer | |
| IL200168A0 (en) | Monoclonal anti-cxcl13 antibodies | |
| FI20070853A0 (fi) | Glykaania sitovat monoklonaaliset vasta-aineet | |
| EP2011869A4 (en) | NEW ANTI-CD98 ANTIBODY | |
| PT3106873T (pt) | Método para a deteção de cancro | |
| HRP20180485T1 (hr) | Monoklonska antitijela za gt468 za liječenje raka | |
| BRPI0817427A2 (pt) | Anticorpo anti-bst2 | |
| PT2024748E (pt) | Anticorpos monoclonais anti-anexina a3 para a deteção de carcinoma da próstata | |
| BRPI0819765A2 (pt) | Conjugados de anticorpos anti-rg-1 | |
| BRPI0715544A2 (pt) | Anticorpos que modificam doença cancerosas. | |
| BRPI0807858A2 (pt) | Anticorpo de modificação de doença cancerosa | |
| DK2094728T3 (da) | Fremgangsmåder til anvendelse for human-adapterende monoklonale antistoffer |